Open account Log in

Exuberance and Optimism Keep Going

Read the article on FBS website

2020_08_11_12_40_37_Template2_Read_Only_PowerPoint.png

USDCHFH4.png

2020_08_11_12_41_31_Template2_Read_Only_PowerPoint.png

GBPUSDH4 (1).png

Midday Market View

Russian health ministry has approved coronavirus vaccine developed by Moscow's Gamaleya Institute. He hopes Russia will start mass production of coronavirus vaccine very soon. European indices are hovering near 2% gains on the session now with US futures also creeping higher.

Midday Key Point

  • Germany August ZEW survey current situation comes at -81.3 vs -69.5 than expected.
  • Russia president Putin says have approved first Russian-produced coronavirus vaccine.

Share with friends:

Similar

Latest news

Instant opening

The website is operated by FBS Markets Inc.; Registration No. 000001317; FBS Markets Inc. is registered by the Financial Services Commission under the Securities Industry Act 2021, license number 000102/6. Office Address: 9725, Fabers Road Extension, Unit 1, Belize City, Belize.

FBS Markets Inc. does not offer financial services to residents of certain jurisdictions, including, but not limited to: the USA, the EU, the UK, Israel, the Islamic Republic of Iran, Myanmar.


Payment transactions are managed by НDС Technologies Ltd.; Registration No. HE 370778; Legal address: Arch. Makariou III & Vyronos, P. Lordos Center, Block B, Office 203, Limassol, Cyprus. Additional address: Office 267, Irene Court, Corner Rigenas and 28th October street, Agia Triada, 3035, Limassol, Cyprus.


Contact number: +357 22 010970; additional number: +501 611 0594.

For cooperation, please contact us via support@fbs.com.


Risk warning: Before you start trading, you should completely understand the risks involved with the currency market and trading on margin, and you should be aware of your level of experience.

Any copying, reproduction, republication, as well as on the Internet resources of any materials from this website is possible only upon written permission.


The information on this website does not constitute investment advice, a recommendation, or a solicitation to engage in any investment activity.

FBS maintains a record of your data to run this website. By pressing the “Accept” button, you agree to our Privacy policy.